As primary providers of pharmaceutical distribution and services to hospitals and other healthcare institutions, the Institutional Pharmacies industry is highly dependent on Medicare funding to support revenue growth. Despite a rise in demand for industry services, and subsequently, the higher sales volumes, shrinking Medicare reimbursements in recent years caused the industry to experience significant revenue loss in 2012 and 2013. However, the industry is expected to perform positively in the five years to 2019 as a result of changing demographics, the continued effects of healthcare reform and expansion of the industry's clinical services.
This industry comprises pharmacies that provide a range of services to residents of nursing homes, hospitals or hospice environments that do not have an on-site pharmacy. In addition to providing pharmaceuticals, institutional pharmacies also provide consulting services, which include monitoring the control, distribution and administration of drugs and assisting with regulation compliance.
The report covers the scope, size, disposition and growth of the industry including the key sensitivities and success factors. Also included are five year industry forecast, growth rates and an analysis of the industry key players and their market shares.